Why isn't there more discussion about repurposed drugs like ivermectin or fenbendazole for treating lymphoma?
The focus in lymphoma treatment has been on therapies with strong clinical evidence showing they work. Current research emphasizes targeted therapies that specifically attack lymphoma cells while causing fewer side Show Full Answer
Why isn't there more discussion about repurposed drugs like ivermectin or fenbendazole for treating lymphoma?
The focus in lymphoma treatment has been on therapies with strong clinical evidence showing they work. Current research emphasizes targeted therapies that specifically attack lymphoma cells while causing fewer side effects than traditional chemotherapy.
These targeted treatments include:
- BTK inhibitors like ibrutinib, acalabrutinib, and zanubrutinib
- Monoclonal antibodies like rituximab that flag cancer cells for destruction
- CAR T-cell therapy that engineers your immune cells to fight cancer
- Immune checkpoint inhibitors that strengthen your immune response
These approaches have undergone rigorous clinical trials and FDA approval processes, demonstrating both safety and effectiveness for lymphoma patients.
Repurposed drugs like ivermectin and fenbendazole haven't been part of mainstream lymphoma discussions because they lack the same level of clinical trial evidence showing they're safe and effective for treating lymphoma specifically. The medical community focuses on treatments with proven results through controlled studies.
If you're interested in newer treatment options, clinical trials offer access to cutting-edge therapies that are being carefully studied. It's always best to discuss any treatment ideas with your oncologist, who can guide you based on your specific type of lymphoma and situation.
December 29, 2025
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
